Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.

Al-Batran SE, Hofheinz RD, Reichart A, Pauligk C, Schönherr C, Schlag R, Siegler G, Dörfel S, Koenigsmann M, Zahn MO, Schubert J, Aldaoud A, Höffkes HG, Schulz H, Hahn L, Uhlig J, Blau W, Stauch M, Weniger J, Wolf M, Jacobasch L, Bildat S, Wehmeyer J, Homann N, Trojan J, Waidmann O, Fietz T, Feustel HP, Groschek M, Wierecky J, Waibel K, Mahlmann S, Schwindel U, Peters U, Schuch G, Pink D, Eschenburg H, Wörns MA, Harich HD, von Weikersthal LF, Däßler KU, Behringer DM, Messmann H, Kretzschmar A, Gallmeier E, Forstbauer H, Kunzmann V, Papke J, Büchner-Steudel P, Vehling-Kaiser U, Springfeld C, Vogel A, Ettrich TJ, Schaaf M, Hausen GZ, Götze TO, Arbeitsgemeinschaft Internistische Onkologie (AIO)

Open source

DOI: 10.1002/ijc.33336
Published: 2021 Mar 15
Container: International journal of cancer
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ijc.33336,
  title = {Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.},
  author = {Al-Batran SE and Hofheinz RD and Reichart A and Pauligk C and Schönherr C and Schlag R and Siegler G and Dörfel S and Koenigsmann M and Zahn MO and Schubert J and Aldaoud A and Höffkes HG and Schulz H and Hahn L and Uhlig J and Blau W and Stauch M and Weniger J and Wolf M and Jacobasch L and Bildat S and Wehmeyer J and Homann N and Trojan J and Waidmann O and Fietz T and Feustel HP and Groschek M and Wierecky J and Waibel K and Mahlmann S and Schwindel U and Peters U and Schuch G and Pink D and Eschenburg H and Wörns MA and Harich HD and von Weikersthal LF and Däßler KU and Behringer DM and Messmann H and Kretzschmar A and Gallmeier E and Forstbauer H and Kunzmann V and Papke J and Büchner-Steudel P and Vehling-Kaiser U and Springfeld C and Vogel A and Ettrich TJ and Schaaf M and Hausen GZ and Götze TO and Arbeitsgemeinschaft Internistische Onkologie (AIO)},
  year = {2021},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.33336},
  url = {https://doi.org/10.1002/ijc.33336}
}

RIS

TY  - JOUR
TI  - Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.
AU  - Al-Batran SE
AU  - Hofheinz RD
AU  - Reichart A
AU  - Pauligk C
AU  - Schönherr C
AU  - Schlag R
AU  - Siegler G
AU  - Dörfel S
AU  - Koenigsmann M
AU  - Zahn MO
AU  - Schubert J
AU  - Aldaoud A
AU  - Höffkes HG
AU  - Schulz H
AU  - Hahn L
AU  - Uhlig J
AU  - Blau W
AU  - Stauch M
AU  - Weniger J
AU  - Wolf M
AU  - Jacobasch L
AU  - Bildat S
AU  - Wehmeyer J
AU  - Homann N
AU  - Trojan J
AU  - Waidmann O
AU  - Fietz T
AU  - Feustel HP
AU  - Groschek M
AU  - Wierecky J
AU  - Waibel K
AU  - Mahlmann S
AU  - Schwindel U
AU  - Peters U
AU  - Schuch G
AU  - Pink D
AU  - Eschenburg H
AU  - Wörns MA
AU  - Harich HD
AU  - von Weikersthal LF
AU  - Däßler KU
AU  - Behringer DM
AU  - Messmann H
AU  - Kretzschmar A
AU  - Gallmeier E
AU  - Forstbauer H
AU  - Kunzmann V
AU  - Papke J
AU  - Büchner-Steudel P
AU  - Vehling-Kaiser U
AU  - Springfeld C
AU  - Vogel A
AU  - Ettrich TJ
AU  - Schaaf M
AU  - Hausen GZ
AU  - Götze TO
AU  - Arbeitsgemeinschaft Internistische Onkologie (AIO)
PY  - 2021
JO  - International journal of cancer
DO  - 10.1002/ijc.33336
UR  - https://doi.org/10.1002/ijc.33336
ER  -

APA

SE, A., RD, H., A, R., C, P., C, S., R, S., G, S., S, D., M, K., MO, Z., J, S., A, A., HG, H., H, S., L, H., J, U., W, B., M, S., J, W., M, W., L, J., S, B., J, W., N, H., J, T., O, W., T, F., HP, F., M, G., J, W., K, W., S, M., U, S., U, P., G, S., D, P., H, E., MA, W., HD, H., LF, V. W., KU, D., DM, B., H, M., A, K., E, G., H, F., V, K., J, P., P, B., U, V., C, S., A, V., TJ, E., M, S., GZ, H., TO, G., & (AIO), A. I. O. (2021). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry.. International journal of cancer. https://doi.org/10.1002/ijc.33336

Source records

pubmed · retrieved 2026-09-26T12:41:49.844Z